Target intelligence / Profile preview

Alpha-2,3-linked sialic acid-bearing glycoproteins

Molecular classification
Glycoprotein, Glycan, Cell surface receptor
01

Overview

Cell-surface 2,3-linked sialic acid-bearing glycoproteins are a class of glycoconjugates where N-acetylneuraminic acid is attached to terminal galactose residues via an alpha-2,3-glycosidic bond (Varki, 2017, Glycobiology, 27(1):3-49). These molecules are predominantly found in the lower respiratory tract of humans and serve as the primary receptors for avian influenza viruses, such as H5N1 and H7N9 (Shinya et al., 2006, Nature, 440(7083):435-436). In contrast, human-adapted influenza viruses typically prefer alpha-2,6-linked sialic acids found in the upper respiratory tract (Nicholls et al., 2007, The Lancet, 370(9602):1841-1851). Beyond their role in viral entry, these glycoproteins are involved in critical biological processes including cell-cell adhesion, signal transduction, and immune system modulation. Therapeutic strategies targeting these molecules often utilize host-directed sialidases, such as DAS181, which enzymatically remove the sialic acid residues to prevent viral attachment and subsequent infection (Malakhov et al., 2006, Antimicrobial Agents and Chemotherapy, 50(4):1470-1479). Additionally, altered expression of these glycoproteins is a hallmark of certain cancers, where they contribute to tumor progression and metastatic potential.

Other names
Alpha-2,3-linked sialylglycoconjugatesNeu5Ac-alpha-2,3-Gal receptorsAvian influenza receptorsSA-alpha-2,3-Gal2,3-sialylated glycoproteins
02

Mechanism of action

Enzymatic cleavage of terminal alpha-2,3-linked sialic acid residues from the host cell surface to prevent viral attachment and entry (Malakhov et al., 2006, Antimicrobial Agents and Chemotherapy, 50(4):1470-1479).

03

Biological functions

Pathogen entry receptorCell-cell adhesionSignal transductionImmune response modulationCellular trafficking
04

Disease associations

Infection (Avian Influenza)Cancer metastasisInflammationViral pathogenesis
05

Safety considerations

Potential disruption of endogenous cell-cell signaling pathwaysMucosal irritation and inflammation in respiratory deliveryImpact on immune cell trafficking and activationOff-target effects on normal physiological glycosylation
06

Interacting drugs

DAS181 (Fludase)

2 more in the full profile.

07

Biomarkers

ST3GAL family sialyltransferase expressionMaackia amurensis leukoagglutinin (MAL) binding intensitySialic acid linkage quantification

Beyond the preview

Go deeper on Alpha-2,3-linked sialic acid-bearing glycoproteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-2,3-linked sialic acid-bearing glycoproteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call